OTR Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $115M
- Underwriters
- Focus
- Unicorns
- SEC Filings
- 1821318
- Public Embarc Page
- https://embarc.com/capital/spac/1821318/OTRA/otr-acquisition
- IPO Ticker
- OTRA
SPAC Leadership
Information on the SPAC leadership.
- Chairman and Chief Executive OfficerNicholas J. Singer
- Chief Financial Officer and DirectorDouglas B. Anderson
- DirectorDavid Neithardt
- DirectorGlenn Gray
- DirectorNadav Besner
Target Information
Information on the SPAC target for merger.
- Company
- Comera Life Sciences
- Presentation
- Investor Presentation (SEC) on 2022-01-31
- Description
- Comera Life Sciences is "developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience."